Welcome to the myNarval App
Discover myNarval, your new companion for visualising your obstructive sleep apnoea and snoring treatment with Narval™ CC.
Your journey to better sleep starts here!
You’ve just created your account… now it’s time to take an active role in your treatment.
Explore everything myNarval offers to help you get the most out of your Narval™ CC device and enhanced your engagement every step of the way.
Your experience, guided step by step
At the heart of your experience is Narval™ CC, a custom-made oral appliance designed to treat mild to severe obstructive sleep apnoea (OSA) and reduce snoring1.
Narval™ CC is designed for adults who snore or have mild to moderate obstructive sleep apnoea. In severe cases, it may be considered if CPAP therapy is ineffective, not tolerated, or refused.
To support you along the way, the myNarval app connects to your compatible O2 ring to provide helpful and encouraging insights about your sleep and your progress:
- Visual feedback: View your oxygen and heart rate data collected by your connected ring.
- Visualise your progress: See the difference between nights with Narval™ CC and nights without it.
- Personalized support: Cleaning tips, care instructions, practical advice… myNarval sends you the right information at the right time.
Ready to get started?
Explore the app, get familiar with it, and let it guide you.
Your sleep deserves you pay attention to it, and myNarval is here to help.
Welcome aboard!
myNarval is not a medical device.
O2 ring is a medical device.
Please refer to the Narval™ CC Instructions for Use and the O2 Ring Instructions for Use for important information regarding contraindications, warnings, and precautions to be taken before and during product use.
Clinical Reference:
1. Vecchierini MF, Attali V, Collet JM, et al. Mandibular advancement device use in obstructive sleep apnoea: ORCADES study 5-year follow-up data. J Clin Sleep Med. 2021;17(8):1695–1705. doi:10.5664/jcsm.9308.
A 5-year prospective, observational, multicenter cohort study of 331 OSA patients. 5-year follow-up data analysis. ClinicalTrials.gov identifier: NCT01326143.